Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Doxycycline prevents malaria by stopping the parasite before it can multiply—but only if taken on schedule. Here is the biology behind the regimen and the timing rules.
Topical ivermectin kills lice but not their eggs—yet clinical trials show it still breaks the infestation cycle. Here's the evidence and how it compares with permethrin.
Crusted (Norwegian) scabies in immunocompromised patients needs several ivermectin doses over weeks, not one. Here is the biology and evidence behind why.
How a bark-derived remedy from the Andes led to two related drugs, and why parasite resistance—not hydroxychloroquine—became malaria's real challenge.
The stage of a brain cyst—alive, dying, or calcified—determines whether albendazole helps, does nothing, or should be avoided entirely.
Doxycycline can cause an exaggerated sunburn through a specific chemical reaction in skin, not a drug allergy. Here is the mechanism and how to protect yourself.
Why a dog dewormer and a human antiparasitic pill are not the same medicine, even when the active molecule looks alike.
A single ivermectin dose cures most strongyloides infections, but in immunosuppressed patients the parasite's internal life cycle can outrun it—here's the biology and the evidence behind extended courses.
A short, well-timed course of doxycycline clears early Lyme disease in most patients. Here's the evidence behind the ten-day standard and who should start treatment without delay.